Back to
Northern Trust Corp.
KPTI
6 quarters
Position history for
Northern Trust Corp.'s holdings in Karyopharm Therapeutics Inc.
Yes. Northern Trust holds 160,006 shares of KPTI (Karyopharm Therapeutics), worth $1.6M, as of its Q2 2026 13F filing. It increased the position from 38,556 shares in Q1 2026. Northern Trust has held KPTI in every 13F on record since Q1 2025, 6 quarterly filings.
Current Value
$1.6M
Current Shares
160,006
Total Value Change
+$1.5M
Total Shares Change
+141,096
Quarter-by-Quarter History
Other major holders of KPTI: RA Capital Management, L.P., Adage Capital Partners GP, L.L.C., Goldman Sachs Group Inc., BlackRock, Inc.